Thelazia

Taxonomy

• Kingdom: Animalia
• Phylum: Nematoda
• Class: Secernentea
• Order: Spirurida
• Family: Thelaziidae
• Genus: Thelazia

General Description
Thelazia is a genus of parasitic nematodes commonly referred to as “eye worms.” Adult worms are slender, filiform, and typically range from 5 mm to 20 mm in length, depending on the species. They inhabit the conjunctival sac, lacrimal ducts, and sometimes the cornea of a variety of mammalian hosts.

Species of Medical and Veterinary Importance

• Thelazia callipaeda – primarily infects dogs, cats, and humans in Europe and parts of Asia.
• Thelazia californiensis – reported in North American canids and felids, with occasional human cases.
• Thelazia lacrymalis – found in cattle, horses, and other ungulates.

Life Cycle

1. Definitive Host: Adult Thelazia reside in the ocular tissues of the definitive host, where they reproduce sexually.
2. Egg Release: Eggs are deposited in the tear fluid and are taken up by intermediate arthropod vectors that feed on ocular secretions.
3. Intermediate Host: Various dipteran flies (e.g., Musca spp., Phortica spp.) act as vectors. Within the fly, eggs develop into first-stage larvae (L1) and subsequently into infective third-stage larvae (L3) over several days to weeks, depending on temperature.
4. Transmission: When the infected fly feeds on the eye secretions of another suitable host, L3 larvae are deposited onto the ocular surface and migrate into the conjunctival sac, where they mature into adult worms, completing the cycle.

Pathology and Clinical Presentation
Infection, termed thelaziasis, may be asymptomatic or cause ocular irritation. Clinical signs include:

• Conjunctivitis (redness, swelling)
• Excessive lacrimation (tear production)
• Photophobia (light sensitivity)
• Corneal ulceration or keratitis in severe cases
• Presence of motile worms visible on the ocular surface

Diagnosis

• Direct ophthalmoscopic or slit‑lamp examination revealing live nematodes.
• Microscopic identification of eggs or larvae in tear fluid.
• Molecular techniques (PCR) can differentiate Thelazia species, though such methods are primarily used in research settings.

Treatment

• Mechanical removal of adult worms using fine forceps under topical anesthesia.
• Topical anti‑nematodal agents (e.g., ivermectin, milbemycin oxime) have been employed, especially in veterinary practice.
• Management of secondary bacterial infections with appropriate ophthalmic antibiotics.

Epidemiology
Thelazia infections are reported worldwide, with higher prevalence in regions where suitable vector flies are abundant and in environments that facilitate close contact between hosts and vectors (e.g., rural or pastoral settings). Human thelaziasis is relatively rare but documented in areas of endemic animal infection.

Prevention

• Control of vector populations through insecticide application and environmental management.
• Regular ocular examination and prophylactic anti‑parasitic treatment in domestic animals living in endemic areas.

Research and Public Health Significance
Thelazia species serve as models for studying host‑parasite interactions in ocular tissues and vector‑mediated transmission dynamics. While human disease is uncommon, awareness among clinicians in endemic regions is important for timely diagnosis and treatment.

References
(Encyclopedic entries typically cite peer‑reviewed literature; specific citations are omitted here to adhere to the instruction against fabricating sources.)